57.4
BioLineRx Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
52.0
FY23:
47.2
FY24:
27.1
FY25:
23.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
24.0
FY22:
24.4
FY23:
16.7
FY24:
11.8
FY25:
17.2
Total assets
Change from FY21 to FY25
millions USD
FY21:
81.4
FY22:
76.4
FY23:
63.9
FY24:
38.9
FY25:
40.9
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.72
FY22:
10.7
FY23:
42.8
FY24:
15.4
FY25:
12.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.59
FY22:
14.9
FY23:
7.92
FY24:
10.0
FY25:
5.44
(positive)
Change from FY21 to FY25
millions USD
FY21:
68.1
FY22:
50.8
FY23:
13.2
FY24:
13.5
FY25:
23.3
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
81.4
FY22:
76.4
FY23:
63.9
FY24:
38.9
FY25:
40.9
All amounts in millions USD